Acadia Pharmaceuticals develops and sells specialized medicines for neurological conditions and rare genetic disorders. Their primary products include treatments for Parkinson's disease psychosis and Rett syndrome, while they continue to research new therapies for other central nervous system diseases. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
